CTAD Breakfast Briefings – Day 3

This activity is supported by an educational grant from Lilly.

Meet the Faculty:

Anna D. Burke, MD 
Karsten Solheim Chair for Dementia 
Director of Alzheimer’s and Memory Disorders Division 
Karsten Solheim Chair for Dementia 
Director of Alzheimer’s and Memory Disorders Division 
Director of Neuropsychiatry 
Department of Neurology 
Barrow Neurological Institute 
Phoenix, AZ 

Abstracts:

Implementation blood biomarkers in clinical practice and trials, Chair: Stephen Salloway, Brown University – Providence (United States)
 
1. Defining the minimum acceptable performance of blood-based biomarkers of Alzheimer’s disease for clinical use in symptomatic patients, Suzanne Schindler, Washington University School of Medicine – St. Louis (United States)
 
2. A highly accurate blood test for Alzheimer’s disease pathology has performance equivalent or superior to clinically used cerebrospinal fluid tests, Oskar Hansson, Lund University – Lund (Sweden)
 

3. Aβ42/Aβ40 and phospho-tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer’s Disease, Robert Rissman, Alzheimer, University California San Diego – San Diego (United States)

Reinforcing Reflections

Earn credit by taking a few minutes to participate in CME Outfitters Reinforcing Reflections, a text-based reflection of how a topic or concept connects to your clinical practice & professional life.

Previous CTAD Breakfast Briefings

Day One

Day Two